FOTO-CELL

What’s New At Innoprot – Fluorescent tau SH-SY5Y Cell Lines

A novel family of cell lines have been developed through stable transfection with different fluorescent isoforms of tau protein and mutants. Each cell line is stably‐transfected and it is ready to use in cell‐based assay applications. These stably transfected cell lines provide consistent levels of tau expression, which helps to simplify the interpretation of the…

Detalles
PHOTO-CELL-LINE

What’s New At Innoprot – September 2.017

The next products have been recently launched: Stable Cell Lines for GPCR Screening: P70545 – M4 cAMP-Nomad Cell Line P70203 – GLP1R cAMP-Nomad Cell Line P70514 – GLP2R cAMP-Nomad Cell Line Primary Cells: P10627 – Mouse Renal Tubular Epithelial Cells P10427 – Mouse Aortic Endothelial Cells

Detalles
PHOTO-PATENT

EPO patent granted

Innoprot is pleased to announce the granting of EPO (European Patent Office) patent on its core GPCR Screening technology on June 7th 2017. Innoprot received notice of the granting of EPO (European Patent Office) patent on its core technology for GPCR Screening. This broadens proprietary protection of the company’s core technology to all European countries.…

Detalles
photo_Bio-Boston

BIO International Convention in San Diego 19-22nd June 2017

19/06/2017 – 22/06/2017  Innoprot will be participating as exhibitors and in the one-on-one partnering in the next BIO International Convention, which will take place in San Diego, CA, from the 19th to 22nd, June, 2017. You can request a meeting with our delegates in the Convention, Dr. Jorge Gamiz, Business Development Director and Dr. Clarisa…

Detalles
photo_Bio-Boston

BIO International Convention in Boston 04-07th June 2017

04/06/2018 – 07/06/2018 Innoprot will be participating in the one-on-one partnering in the next BIO International Convention, which will take place Boston, MA, from the 4th to 7th, June, 2017. You can request a meeting with our delegate in the Convention, Mr. Jorge Gamiz, Business Development Director. Innoprot will be showing our latest advances in…

Detalles

ADPD 2017 – The 13th International Conference on Alzheimers & Parkinsons Diseases

Innoprot will be present in the AD/PD 2017, the 13th International Conference on Alzheimer’s / Parkinson’s Diseases, which will take place in Viena, Austria from 29th, March to 2nd, April, 2017. AD/PDTM 2017, the 13th​ International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders, will build on the well-earned reputation of previous AD/PDTM​…

Detalles

Myocardial fibrosis: biomedical research from bench to bedside

Myocardial fibrosis refers to a variety of quantitative and qualitative changes in the interstitial myocardial collagen network that occur in response to cardiac ischaemic insults, systemic diseases, drugs, or any other harmful stimulus affecting the circulatory system or the heart itself. Myocardial fibrosis alters the architecture of the myocardium, facilitating the development of cardiac dysfunction,…

Detalles

Mitochondria in the context of Parkinson’s disease

Parkinson’s disease (PD) is the second most common neurodegenerative disease, affecting 1–2% of the population over the age of 65. Rigidity, bradikynesia, postural instability and tremor are the principal clinical characteristics of this disease, caused by the progressive loss and degeneration of dopaminergic neurons in the Substantia nigra pars compacta (SNpc). Tremor and motor impairment…

Detalles